136 related articles for article (PubMed ID: 21345510)
1. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
Radiother Oncol; 2011 Mar; 98(3):387-93. PubMed ID: 21345510
[TBL] [Abstract][Full Text] [Related]
2. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.
Damaraju S; Murray D; Dufour J; Carandang D; Myrehaug S; Fallone G; Field C; Greiner R; Hanson J; Cass CE; Parliament M
Clin Cancer Res; 2006 Apr; 12(8):2545-54. PubMed ID: 16638864
[TBL] [Abstract][Full Text] [Related]
3. Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients.
Fachal L; Gómez-Caamaño A; Peleteiro P; Carballo A; Calvo-Crespo P; Sánchez-García M; Lobato-Busto R; Carracedo A; Vega A
Radiother Oncol; 2012 Dec; 105(3):321-8. PubMed ID: 23075580
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
De Ruyck K; Van Eijkeren M; Claes K; Morthier R; De Paepe A; Vral A; De Ridder L; Thierens H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1140-9. PubMed ID: 15990020
[TBL] [Abstract][Full Text] [Related]
5. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
6. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C
Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413
[TBL] [Abstract][Full Text] [Related]
7. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Serafini F; Cambria R; Vavassori A; Cattani F; Garibaldi C; Gherardi F; Ferrari A; Rocco B; Scardino E; de Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):26-34. PubMed ID: 20133085
[TBL] [Abstract][Full Text] [Related]
8. [Acute toxicity in 50 patients with prostate cancer treated with conformal radiation therapy].
Nasr E; Merhej S; Nehme Nasr D; Fares G
J Med Liban; 2001; 49(6):325-8. PubMed ID: 12744634
[TBL] [Abstract][Full Text] [Related]
9. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients.
Lin C; Turner S; Mai T; Kneebone A; Gebski V
Australas Radiol; 2007 Dec; 51(6):578-83. PubMed ID: 17958696
[TBL] [Abstract][Full Text] [Related]
10. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
11. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.
Pugh TJ; Keyes M; Barclay L; Delaney A; Krzywinski M; Thomas D; Novik K; Yang C; Agranovich A; McKenzie M; Morris WJ; Olive PL; Marra MA; Moore RA
Clin Cancer Res; 2009 Aug; 15(15):5008-16. PubMed ID: 19638463
[TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.
Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB
Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577
[TBL] [Abstract][Full Text] [Related]
13. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Eble MJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):835-41. PubMed ID: 16289911
[TBL] [Abstract][Full Text] [Related]
14. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
[TBL] [Abstract][Full Text] [Related]
15. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
[TBL] [Abstract][Full Text] [Related]
16. Impact of dose and volume on rectal tolerance.
Gambacorta MA; Manfrida S; D'Agostino G; Digesù C; D'Onofrio I; Rosato H; Valentini V
Rays; 2005; 30(2):181-7. PubMed ID: 16294912
[TBL] [Abstract][Full Text] [Related]
17. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
18. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
[TBL] [Abstract][Full Text] [Related]
19. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion.
Yacoub A; Park JS; Qiao L; Dent P; Hagan MP
Int J Radiat Biol; 2001 Oct; 77(10):1067-78. PubMed ID: 11682011
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life after radiotherapy for prostate cancer].
Joly F; Degrendel AC; Guizard AV
Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
